Mycophenolate mofetil prevents the progression of chronic kidney allograft nephropathy

被引：3
|
作者：
Park, JH
Park, JH
Yang, CW
Kim, YS
Kim, SY
Moon, IS
Koh, YB
Bang, BK
机构：
[1] Catholic Univ Korea, Kangnam St Marys Hosp, Dept Internal Med, Seocho Ku, Seoul 137040, South Korea
[2] Catholic Univ Korea, Kangnam St Marys Hosp, Dept Surg, Seocho Ku, Seoul 137040, South Korea
来源：
TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 07期
关键词：
D O I：
10.1016/S0041-1345(00)01393-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1747 / 1747
页数：1
相关论文
共 50 条
  • [31] A randomized trial of mycophenolate mofetil versus azathioprine as calcineurin inhibitor sparing agents in the treatment of chronic allograft nephropathy
    Metcalfe, MS
    Jain, S
    Waller, JR
    Saunders, RN
    Bicknell, GR
    Nicholson, ML
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1812 - 1814
  • [32] A randomised trial of mycophenolate mofetil versus azathioprine as calcineurin inhibitor sparing agents in the treatment of chronic allograft nephropathy
    Brook, NR
    Metcalfe, MS
    Jain, S
    Bicknell, GR
    Nicholson, ML
    BRITISH JOURNAL OF SURGERY, 2003, 90 : 22 - 22
  • [33] Lower incidence of chronic allograft nephropathy at 1 year post-transplantation in patients treated with mycophenolate mofetil
    Merville, P
    Bergé, F
    Deminière, C
    Morel, D
    Chong, G
    Durand, D
    Rostaing, L
    Mourad, G
    Potaux, L
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (11) : 1769 - 1775
  • [34] Chronic allograft nephropathy: Effect of cyclosporine reduction and addition of mycophenolate on progression of renal disease.
    Weir, MR
    Fink, JC
    Hanes, DS
    Traver, M
    Young, C
    Schofield, K
    Blahut, S
    Klassen, DK
    Cangro, CB
    Schweitzer, E
    Bartlett, ST
    TRANSPLANTATION, 1999, 67 (07) : S82 - S82
  • [35] Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus
    Daly, I
    Jain, A
    Reyes, J
    Fung, J
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1503 - 1503
  • [36] Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function
    Fritsche, L
    Sperschneider, H
    Budde, K
    Giessing, M
    Türk, H
    Böhler, T
    Schröder, K
    Stein, G
    Neumayer, HH
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 2229 - 2229
  • [37] Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection
    Kato, T
    Ruiz, P
    DeFaria, W
    Weppler, D
    Khan, F
    Pinna, A
    Nery, J
    Tzakis, A
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 396 - 396
  • [38] Mycophenolate mofetil and reduction in cyclosporine dosage for chronic renal allograft dysfunction
    Islam, MS
    Francos, GC
    Dunn, SR
    Burke, JF
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 2230 - 2231
  • [39] Conversion of azathioprine to mycophenolate mofetil and chronic graft failure progression
    Lezaic, VD
    Marinkovic, J
    Ristic, S
    Dokic, ZM
    Jovanovic, GB
    Radivojevic, DM
    Blagojevic, RN
    Djukanovic, LD
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 734 - 736
  • [40] LONG TERM GRAFT FUNCTION IN PEDIATRIC RENAL TRANSPLANT PATIENTS WITH CHRONIC ALLOGRAFT NEPHROPATHY RECEIVING MYCOPHENOLATE MOFETIL.
    Prince, Nicholas J.
    McCulloch, Mignon I.
    Kerecuk, Larissa
    Walsh, Grainne
    Taylor, Judy
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 56 - 56
12345